Article Details

Sanford C. Bernstein Reaffirms Market Perform Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)

Retrieved on: 2019-10-17 19:37:30

Tags for this article:

Click the tags to see associated articles and topics

Sanford C. Bernstein Reaffirms Market Perform Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ). View article details on hiswai:

Excerpt

<div><b>AQR Capital Management</b> LLC boosted its holdings in Jazz Pharmaceuticals by 46.9% in the 2nd quarter. <b>AQR Capital Management</b> LLC now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up